Glucocorticoid_NN
receptors_NNS
,_,
fibromyalgia_NN
and_CC
low_JJ
back_JJ
pain_NN
._.

Recently_RB
,_,
fibromyalgia_NN
-LRB-_-LRB-
FMS_NN
-RRB-_-RRB-
was_VBD
shown_VBN
to_TO
be_VB
a_DT
disorder_NN
associated_VBN
with_IN
an_DT
altered_JJ
functioning_NN
of_IN
the_DT
stress_NN
response_NN
system_NN
._.

FMS_NN
patients_NNS
display_VBP
a_DT
hyperreactive_JJ
pituitary_JJ
adrenocorticotropic_JJ
hormone_NN
-LRB-_-LRB-
ACTH_NN
-RRB-_-RRB-
release_NN
in_IN
response_NN
to_TO
corticotropin-releasing_JJ
hormone_NN
-LRB-_-LRB-
CRH_NN
-RRB-_-RRB-
and_CC
to_TO
insulin-induced_JJ
hypoglycemia_NN
._.

We_PRP
suggested_VBD
that_IN
negative_JJ
feedback_NN
of_IN
cortisol_NN
could_MD
be_VB
deranged_VBN
._.

Therefore_RB
we_PRP
investigated_VBD
the_DT
properties_NNS
and_CC
function_NN
of_IN
the_DT
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
in_IN
FMS_NN
patients_NNS
and_CC
compared_VBD
the_DT
results_NNS
with_IN
those_DT
of_IN
healthy_JJ
persons_NNS
and_CC
patients_NNS
with_IN
chronic_JJ
low_JJ
back_JJ
pain_NN
-LRB-_-LRB-
LBP_NN
a_DT
localized_JJ
pain_NN
condition_NN
-RRB-_-RRB-
._.

Forty_CD
primary_JJ
FMS_NN
patients_NNS
-LRB-_-LRB-
F_NN
:_:
M_NN
=_JJ
36_CD
:_:
4_CD
-RRB-_-RRB-
,_,
28_CD
LBP_NN
patients_NNS
-LRB-_-LRB-
25_CD
:_:
3_CD
-RRB-_-RRB-
and_CC
14_CD
-LRB-_-LRB-
12_CD
:_:
2_CD
-RRB-_-RRB-
healthy_JJ
,_,
sedentary_JJ
control_NN
persons_NNS
were_VBD
recruited_VBN
for_IN
the_DT
study_NN
._.

Urinary_JJ
free_JJ
cortisol_NN
excretion_NN
in_IN
FMS_NN
and_CC
LBP_NN
patients_NNS
was_VBD
lower_JJR
compared_VBN
to_TO
controls_NNS
._.

Only_RB
FMS_NN
patients_NNS
displayed_VBD
lower_JJR
CBG_NN
and_CC
basal_JJ
serum_NN
cortisol_NN
concentrations_NNS
when_WRB
compared_VBN
to_TO
controls_NNS
._.

However_RB
,_,
plasma_NN
free_JJ
cortisol_NN
concentrations_NNS
were_VBD
similar_JJ
in_IN
the_DT
three_CD
groups_NNS
._.

There_EX
was_VBD
no_DT
difference_NN
in_IN
the_DT
number_NN
of_IN
GR_NN
per_IN
cell_NN
among_IN
the_DT
three_CD
groups_NNS
-LRB-_-LRB-
FMS_NNP
:_:
6498_CD
+_CC
\/_NN
-_:
252_CD
,_,
LBP_NN
:_:
6625_CD
+_CC
\/_CD
-_:
284_CD
,_,
controls_NNS
:_:
6576_CD
+_CC
\/_CD
-_:
304_CD
-RRB-_-RRB-
,_,
but_CC
the_DT
dissociation_NN
constant_NN
-LRB-_-LRB-
Kd_NN
-RRB-_-RRB-
of_IN
the_DT
FMS_NN
-LRB-_-LRB-
14.5_CD
+_CC
\/_CD
-_:
0.9_CD
nmol\/l_NN
-RRB-_-RRB-
and_CC
LBP_NN
-LRB-_-LRB-
14.7_CD
+_CC
\/_CD
-_:
1.3_CD
nmol\/l_NN
-RRB-_-RRB-
subjects_NNS
was_VBD
significantly_RB
higher_JJR
than_IN
that_DT
of_IN
the_DT
controls_NNS
-LRB-_-LRB-
10.9_CD
+_CC
\/_NN
-_:
0.8_CD
nmol\/l_NN
-RRB-_-RRB-
-LRB-_-LRB-
p_NN
&lt;_JJR
.05_CD
-RRB-_-RRB-
._.

The_DT
maximal_JJ
stimulation_NN
of_IN
the_DT
lymphocytes_NNS
,_,
as_IN
measured_VBN
by_IN
the_DT
maximal_JJ
thymidine_NN
incorporation_NN
-LRB-_-LRB-
in_IN
the_DT
absence_NN
of_IN
cortisol_NN
-RRB-_-RRB-
in_IN
the_DT
FMS_NN
group_NN
was_VBD
approximately_RB
1.5_CD
times_NNS
higher_JJR
-LRB-_-LRB-
p_NN
&lt;_JJR
.05_CD
-RRB-_-RRB-
than_IN
in_IN
the_DT
control_NN
or_CC
LBP_NN
group_NN
._.

The_DT
ED50_NN
-LRB-_-LRB-
the_DT
cortisol_NN
concentration_NN
giving_VBG
50_CD
%_NN
inhibition_NN
of_IN
the_DT
thymidine_NN
incorporation_NN
-RRB-_-RRB-
,_,
however_RB
,_,
was_VBD
identical_JJ
in_IN
all_DT
three_CD
groups_NNS
._.

We_PRP
conclude_VBP
that_IN
FMS_NN
patients_NNS
have_VBP
a_DT
mild_JJ
hypocortisolemia_NN
,_,
increased_VBN
cortisol_NN
feedback_NN
resistance_NN
in_IN
combination_NN
probably_RB
with_IN
a_DT
reduced_VBN
CRH_NN
synthesis_NN
or_CC
release_NN
in_IN
the_DT
hypothalamus_NN
._.

The_DT
role_NN
of_IN
the_DT
GR_NN
and_CC
mineralocorticoid_NN
receptor_NN
-LRB-_-LRB-
MR_NN
-RRB-_-RRB-
in_IN
the_DT
CRH_NN
regulation_NN
in_IN
the_DT
FMS_NN
patients_NNS
remains_VBZ
to_TO
be_VB
solved_VBN
._.

